Phase (Ph) I evaluation of the dolastatin analogue synthadotin (SYN-D; ILX651): Pooled data analysis of three alternate schedules in patients (pts) with advanced solid tumorsL. A. Hammond, Eric K. Rowinsky, Casey Cunningham et al.|Journal of Clinical Oncology|2004Cited by 8